Paradigm Shift in the Treatment of Meningiomas.

Adv Exp Med Biol

Center for Neurosurgery, University Hospital of Cologne, Cologne, Germany.

Published: July 2023

Meningiomas are the most common brain tumor in adults with rising incidence rates due to an aging population globally, increased availability of neuroimaging, and increased awareness of this condition by treating clinicians and primary care physicians. Surgical resection remains the mainstay of treatment, with adjuvant radiotherapy reserved for higher grade meningiomas or tumors that undergo incomplete resections. Whereas these tumors were classically defined by their histopathological features and subtypes, recent work has uncovered the molecular alterations that may lead to tumor development and have important prognostic implications. However, there remain important clinical questions regarding the management of meningiomas and current clinical guidelines continue to evolve as additional studies add onto the growing body of work that enables us to better understand these tumors.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-031-29750-2_1DOI Listing

Publication Analysis

Top Keywords

paradigm shift
4
shift treatment
4
treatment meningiomas
4
meningiomas meningiomas
4
meningiomas common
4
common brain
4
brain tumor
4
tumor adults
4
adults rising
4
rising incidence
4

Similar Publications

Preserved but Un-Sustained Responses to Bids for Dyadic Engagement in School-Age Children with Autism.

J Autism Dev Disord

January 2025

Center for Child Health, Behavior and Development, Seattle Children's Research Institute, 1920 Terry Ave CURE-3, Seattle, WA, 98101, USA.

Purpose: Dynamic eye-tracking paradigms are an engaging and increasingly used method to study social attention in autism. While prior research has focused primarily on younger populations, there is a need for developmentally appropriate tasks for older children.

Methods: This study introduces a novel eye-tracking task designed to assess school-aged children's attention to speakers involved in conversation.

View Article and Find Full Text PDF

Landscape analysis of adverse events and dose intensity for FDA approved oncology small molecules.

Cancer Chemother Pharmacol

January 2025

Clinical Pharmacology and Translational Sciences, Pfizer Worldwide R&D, 10555 Science Center Drive, San Diego, CA, 92121, USA.

As development of new oncology small molecule therapies is focused mainly on molecularly targeted agents, the dose selection paradigm has shifted from the maximum tolerated dose (MTD)-based approach traditionally utilized with cytotoxic drugs towards determining an optimal dose with long-term tolerability while maintaining efficacy. To assess overall tolerability in recently approved oncology small molecules, we surveyed 54 compounds approved by the FDA since March 2017 with respect to dose intensity, dose modifications, and treatment emergent adverse events (TEAEs). Of the 54 new molecular entities surveyed, only 15 were approved at a label dose equal to the MTD (Label Dose = MTD).

View Article and Find Full Text PDF

Nanotechnology and nanobots unleashed: pioneering a new era in gynecological cancer management - a comprehensive review.

Cancer Chemother Pharmacol

January 2025

Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, Bibinagar, Hyderabad, Telangana, 508126, India.

Introduction: Gynecological cancers, such as ovarian, cervical, and endometrial malignancies, are notoriously challenging due to their intricate biology and the critical need for precise diagnostic and therapeutic approaches. In recent years, groundbreaking advances in nanotechnology and nanobots have emerged as game-changers in this arena, offering the promise of a new paradigm in cancer management. This comprehensive review delves into the revolutionary potential of these technologies, showcasing their ability to transform the landscape of gynecological oncology.

View Article and Find Full Text PDF

Professional Identity Formation in Indian Undergraduate Medical Students.

Indian Pediatr

January 2025

NAMS Emeritus Professor; Chair, Center for Health Professions Education, Adesh University, Bathinda, Punjab, India. Correspondence to: Prof. Tejinder Singh, 221-D/1, BRS Nagar, Ludhiana 141012, Punjab, India.

Medical training in India is experiencing a paradigm shift. The competency-based medical education (CBME) for undergraduate medical training was adopted from the admission session 2019. The Indian Medical Graduate (IMG) was identified under CBME, by explicitly documenting its roles viz.

View Article and Find Full Text PDF

Effects of Light and Laser Therapies on the Microecosystem of Sebaceous Glands in Acne Treatment.

Photodermatol Photoimmunol Photomed

January 2025

Department of Dermatology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China.

Background: Acne vulgaris (acne) is one of the most common skin diseases with complex pathogenesis. Numerous studies have shown that the microecosystem of sebaceous glands and Cutibacterium acnes play key roles in its pathogenesis. Antibiotics targeting C.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!